Klavux (Amoxicillin, Clavulanic Acid)

Amoxicillin interferes with bacterial cell wall synthesis by binding to penicillin‑binding proteins, causing cell lysis. Clavulanic acid inhibits beta‑lactamase enzymes produced by resistant bacteria, protecting amoxicillin from degradation and extending its antibacterial activity against a wider range of pathogens.

The dosage of Klavux is individualized by the prescribing clinician based on the infection type, severity, patient age, weight, renal function and other clinical factors. No fixed regimen is provided here; the prescriber will set the appropriate dose and schedule.

Safety data for Klavux in pregnancy and lactation are limited, and the pregnancy category is listed as unknown. Healthcare providers should evaluate the potential benefits against possible risks before prescribing to pregnant or nursing women.

To place an order, submit an enquiry on the Klavux product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Klavux combines amoxicillin with clavulanic acid, offering protection against beta‑lactamase‑producing bacteria that can render amoxicillin ineffective. This broader spectrum makes Klavux suitable for infections where resistance to amoxicillin alone is a concern, whereas amoxicillin alone may be sufficient for susceptible organisms.

Klavux should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture and direct sunlight to maintain stability and potency throughout its shelf life.

Klavux is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with food may reduce gastrointestinal upset in some patients. The exact dosing schedule is determined by the prescriber.

Serious adverse events include anaphylaxis, severe allergic reactions, Clostridioides difficile‑associated colitis, and significant liver enzyme elevations. Patients should seek immediate medical attention if they experience symptoms such as difficulty breathing, severe diarrhea, jaundice, or unexplained rash.

Klavux is contraindicated in individuals with a known hypersensitivity to amoxicillin, clavulanic acid, or other penicillins. It should also be used with caution in patients with severe hepatic impairment or a history of severe allergic reactions to beta‑lactam antibiotics.